The effect of smoking cessation pharmacotherapies on pancreatic beta cell function
about
Metabolic effects of smoking cessationSmoking and the risk of type 2 diabetes.Therapeutic concentrations of antidepressants inhibit pancreatic beta-cell function via mitochondrial complex inhibition.Ameliorative effect of nicotine exposure on insulin resistance is accompanied by decreased cardiac glycogen synthase kinase-3 and plasminogen activator inhibitor-1 during oral oestrogen-progestin therapy.Postnatal metabolic and reproductive consequences of fetal and neonatal exposure to the smoking cessation drug bupropion.
P2860
The effect of smoking cessation pharmacotherapies on pancreatic beta cell function
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The effect of smoking cessation pharmacotherapies on pancreatic beta cell function
@en
The effect of smoking cessation pharmacotherapies on pancreatic beta cell function.
@nl
type
label
The effect of smoking cessation pharmacotherapies on pancreatic beta cell function
@en
The effect of smoking cessation pharmacotherapies on pancreatic beta cell function.
@nl
prefLabel
The effect of smoking cessation pharmacotherapies on pancreatic beta cell function
@en
The effect of smoking cessation pharmacotherapies on pancreatic beta cell function.
@nl
P2093
P2860
P1476
The effect of smoking cessation pharmacotherapies on pancreatic beta cell function
@en
P2093
Alison C Holloway
Amanda K Woynillowicz
Catherine J Nicholson
Sandeep Raha
P2860
P304
P356
10.1016/J.TAAP.2012.08.020
P577
2012-08-27T00:00:00Z